Sunday, June 1, 2025
21.5 C
Bengaluru

Doctors Day with a Difference

[wpfilebase tag=file id=113 tpl=download-button /]

Inside this Issue

1. Editorial: Doctor’s Day with a Difference!

MedicinMan reports on a unique celebration of the special day in Mangaluru, Karnataka, organized by a prominent city surgeon and professor and honoring the work of anganwadi workers, medical representatives and the District Health Officer.

2. Briefing the Design Agency: A Skill Oft-Neglected by Pharma Brand Managers by Vivek Hattangadi

The design brief can make or break a brand campaign; here’s how to get it right.

3. Indian Pharma Highlights for June 2018 by IQVIA

The Indian pharma market clocked 10,460 Crores for month of June with a robust growth at 12.8%. Here are the biggest winners.

4. Pharma’s Silver Lining Continues to Broaden by Salil Kallianpur

Salil Kallianpur, Executive Editor, MedicinMan, comments on the IQVIA numbers for June 2018

5. Pharmacology Refresher: Drugs Acting on the Nitric Oxide Pathway by Dr. Anand Lakhar

The nitric oxide pathway in the human body is key to the treatment of a variety of diseases from angina to erectile dysfunction

6. Philips Launches India’s 1st Future Health Index by Press Release

The FHI is “a research-based platform that helps to determine the readiness of countries to address global health challenges”

7. Book Review: Encyclopedia of Nobel Laureates

Download the issue here: PDF

Hot this week

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?

Tata 1mg App Business Model: How does it work...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

Topics

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Nimesulide – Nice or Not Nise?

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...
spot_img

Related Articles

spot_imgspot_img